Killer cell immunotherapy can treat advanced pancreatic cancer
Researchers at the University of New South Wales in Sydney and the California Institute of Biomedicine (CALIBR) have demonstrated that "specially cultured killer cells" can be used to treat pancreatic cancer. In the study, the te..
Latest immunotherapy in liver cancer treatment
Liver cancer Liver cancer is currently the fifth most common cause of cancer-related death in the world. The current first-line systemic treatment drug is mainly sorafenib, but usually only prolongs the overall survival of 3 mont..
NK Cell immunotherapy in advanced liver cancer cases
Cases of NK cell immunotherapy for advanced liver cancer 92-year-old advanced cancer patient has complete remission Seven years ago, Ms. M, who was in her 80s, was diagnosed with hepatocellular carcinoma (caused by cancer in the p..
Cell immunotherapy for prevention, recurrence, and metastasis of liver cancer
The incidence of liver cancer in China is very high, because liver cancer is difficult to find in the early stage of the disease. Once the diagnosis is often in the middle and late stages, the optimal treatment time is often misse..
CAR T, CAR T-Cell, Cell therapy, EGFR, EGFR806, GPC3, PC-T cells, Sun Yat-sen, TGF β
CAR T-Cell therapy approvals and availability
July 2021: In June 2014, KITE Biotechnology Company, with only 19 employees, was listed on NASDAQ in the United States, and it took 130 million US dollars in one day! Just two months later, Juno Biotechnology had less than 20 em..
proton therapy, Proton therapy in NCI, Proton therapy in singapore
Proton therapy for a ten-year-old girl with astrocytoma
Proton therapy in astrocytma was tried in 2012 for the first time.In 2012, Annabelle was diagnosed with fibroblastic astrocytoma, a brain tumor. Surgery removed most of the tumor but unfortunately the tumor relapsed in 2014.He re..
CAR T-Cell, Cell therapy, Solid tumors
CAR T-Cell therapy in solid tumors
July 2021: CAR T-Cell therapy in solid tumors has been approved in China with certain indications and markers. Recently, CAR T-Cell therapy is been tested for solid cancers like : Breast cancer Non-small-cell lung cancer ..
Kite, Kymriah, Novartis, Yeskarta
CAR NK therapy has an effective rate of 73%
Immunotherapy in treatment of cancerCancer CAR-NK therapy has an effective rate of 73%, and is being recruited in domestic clinical trials.Immunotherapy has revolutionized the way cancer is treated. Cancer immunotherapy is divide..
First immunotherapy approved for esophageal cancer
First immunotherapy has been approved for esophageal cancer treatment. Esophageal cancer is a common malignant tumor. The International Center for Cancer Research of the World Health Organization points out that esophageal cancer..
CAR NK, Immunotherapy
CAR natural killer cell therapy – MD Anderson partners with Takeda
The University of Texas MD Anderson Cancer Center and Takeda Pharmaceutical Company Limited have entered a restrictive understanding and research consent to develop and market chimeric antigen receptor directed natural killer (CAR..